» Articles » PMID: 37440573

Methionine Metabolism and Endocrine Function of the Pituitary Gland in Patients with Suprasellar Germinoma

Overview
Journal PLoS One
Date 2023 Jul 13
PMID 37440573
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of this study was to investigate the association between methionine (MET) metabolism and endocrine function of the pituitary gland in patients with suprasellar region tumor.

Materials And Methods: Twenty patients with intracranial germinoma were included in this study. Initial staging and all surveillance MET PET/CT scans and comparable serum levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), and thyroid stimulating hormone (TSH) were analyzed. The patients were divided into two groups according to tumor location, with tumors in the suprasellar region (condition) or not (control). MET uptake of the pituitary gland (i.e., SUVR [standardized uptake value ratio]) and levels of FSH, LH, TSH were compared in the condition and control groups and in the before and after treatment phases of each group.

Results: The SUVR in the control group was like that found in normal pituitary glands in previous studies, whereas the SUVR of the untreated condition group was high and that of treated condition group was low with significance compared to the control group. Serum levels of pituitary hormones in before and after treatment condition groups were significantly lower than those in the control group. The FSH and LH levels of curatively treated patients in the control group were positively correlated with SUVR with respective ß values of 3.71 and 0.98 (p < .001). The TSH level of the treated condition group was negatively correlated with SUVR (ß = -1.02, p < .001).

Conclusion: This study is the first known investigation to examine the association between MET metabolism and endocrine function of the pituitary gland, and it confirmed that MET metabolism reflects endocrine function. A future study validating the result of correlation analysis is warranted.

References
1.
Calaminus G, Kortmann R, Worch J, Nicholson J, Alapetite C, Garre M . SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation.... Neuro Oncol. 2013; 15(6):788-96. PMC: 3661100. DOI: 10.1093/neuonc/not019. View

2.
Chang H, Chiu C, Jung S, Wong A, Wu C, Lo F . Neurological and endocrinological manifestations of 49 children with intracranial pure germinoma at initial diagnosis in Taiwan. Pediatr Neonatol. 2020; 62(1):106-112. DOI: 10.1016/j.pedneo.2020.07.017. View

3.
Roy A . Estimating correlation coefficient between two variables with repeated observations using mixed effects model. Biom J. 2006; 48(2):286-301. DOI: 10.1002/bimj.200510192. View

4.
Lee S, Jung K, Ha J, Oh C, Kim H, Park H . Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005-2012. Cancer Res Treat. 2016; 49(2):494-501. PMC: 5398392. DOI: 10.4143/crt.2016.129. View

5.
Crowne E, Gleeson H, Benghiat H, Sanghera P, Toogood A . Effect of cancer treatment on hypothalamic-pituitary function. Lancet Diabetes Endocrinol. 2015; 3(7):568-76. DOI: 10.1016/S2213-8587(15)00008-X. View